4.23
Katherine Unger Baillie
Science News Officer
kbaillie@upenn.edu
Cancer Research
Expanding opportunities to leverage science in the clinic
Patricia Corby, who recently joined the School of Dental Medicine as associate dean for translational research, is bringing her research to bear for cancer patients undergoing radiation, while looking to advance clinical research School-wide.
Topical targeted therapies show promise in treatment of skin cancer
A Penn study finds fewer side effects with small-molecule kinase inhibitors compared to standard ointment when treating precancerous skin lesions.
The Power of Penn at the Met
One year into the Power of Penn campaign, President Amy Gutmann hosted a panel discussion with three professors to usher in another year of inclusion, innovation, and impact on a local and global scale.
Cancer most frequently spreads to the liver. Here’s why.
Researchers from the Abramson Cancer Center shows hepatocytes, the chief functional cells of the liver, orchestrate the “seed and soil” process for cancer to spread to the liver.
For melanoma patients, one dose of immunotherapy before surgery can lead to remission
An Abramson Cancer Center study finds that with a single dose of a PD-1 inhibitor, immune responses can peak in just one week.
25 years of integration, innovation, and ideals
2018 marked 25 years since the University of Pennsylvania Health System (UPHS) was first established—a milestone that would undoubtedly make the institution’s founder, Benjamin Franklin, proud.
Energizing the immune system to eat cancer
An Abramson Cancer Center study identifies a method of priming macrophages to boost an anti-tumor response wherein macrophages attack and eat cancer cells.
Hindering melanoma metastasis with an FDA-approved drug
A drug approved by the FDA 65 years ago for blood pressure control may aid in preventing cancer from spreading to distant organs. New research led by Serge Fuchs revealed that this drug disrupted formation of a fertile environment for metastasis by protecting healthy cells from harmful vesicles released by tumors.
Resistance to cancer treatment is a chain reaction
A study identifies a chain reaction in cells that enables cancer to resist treatments that target BRAF mutations.
Doctors can weigh in on brain tumors remotely
Brain tumor patients will now have access to Penn Medicine’s cancer expertise through the new telemedicine second opinion program for brain tumors.
Media Contact
Experts
In the News
HealthDay News
For Breast Cancer Patients, Less Time on Hormonal Meds?
Susan Domchek of the Perelman School of Medicine and the Abramson Cancer Center comments on hormonal therapy.
FULL STORY →
Nature
Acupuncture in Cancer Study Reignites Debate About Controversial Technique
Rollin Gallagher of the Perelman School of Medicine comments on a clinical trial that focused on whether acupuncture can relieve pain in cancer patients.
FULL STORY →